Refractory Epstein-Barr Virus (EBV)-related post-transplant lymphoproliferative disease : cure by combined brentuximab vedotin and allogeneic EBV-specific T-lymphocytes
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Erschienen in
-
In: Frontiers in medicine, 6, Artikel 295, S. 295-1-295-5
- Ereignis
-
Veröffentlichung
- (wo)
-
Bochum
- (wer)
-
Ruhr-Universität Bochum
- (wann)
-
2019
- Urheber
-
Mika, Thomas
Strate, Katharina
Ladigan, Swetlana
Aigner, Clemens
Schlegel, Uwe
Tischoff, Iris
Tischer-Zimmermann, Sabine
Eiz-Vesper, Britta
Maecker-Kolhoff, Britta
Schroers, Roland
- URN
-
urn:nbn:de:hbz:294-77480
- Rechteinformation
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
15.08.2025, 07:30 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Mika, Thomas
- Strate, Katharina
- Ladigan, Swetlana
- Aigner, Clemens
- Schlegel, Uwe
- Tischoff, Iris
- Tischer-Zimmermann, Sabine
- Eiz-Vesper, Britta
- Maecker-Kolhoff, Britta
- Schroers, Roland
- Ruhr-Universität Bochum
Entstanden
- 2019
Ähnliche Objekte (12)
Endoscopic detection of an early manifestation of EBV-related post-transplant lymphoproliferative disorder in a transplanted colon
Post-transplant lymphoproliferative disorders
Post-transplant lymphoproliferative disease
Case-report: EBV driven lymphoproliferative disorder associated with Ruxolitinib
Adoptive Cell Transfer of Allogeneic Epstein-Barr Virus-Specific T Lymphocytes for Treatment of Refractory EBV-Associated Posttransplant Smooth Muscle Tumors : A Case Report
Characterization of Epstein-Barr virus (EBV)-infected cells in EBV-associated hemophagocytic lymphohistiocytosis in two patients with X-linked lymphoproliferative syndrome type 1 and type 2
Post-transplant Epstein–Barr Virus-Related Lymphoproliferative Disorder: A Case Report and Review of Literature
Automated quantification of Epstein-Barr virus in whole blood for post-transplant lymphoproliferative disorders monitoring
Expert Consensus on the Characteristics of Patients with Epstein–Barr Virus-Positive Post-Transplant Lymphoproliferative Disease (EBV+ PTLD) for Whom Standard-Dose Chemotherapy May be Inappropriate: A Modified Delphi Study
CAR-T cells targeting Epstein-Barr virus gp350 validated in a humanized mouse model of EBV infection and lymphoproliferative disease
Frequenz und Phänotyp Epstein-Barr Virus (EBV)-spezifischer T-Lymphozyten im Verlauf asymptomatischer EBV-Reaktivierungen gesunder Virusträger
Epstein–Barr virus (EBV) and polyomaviruses are detectable in oropharyngeal cancer and EBV may have prognostic impact
Endoscopic detection of an early manifestation of EBV-related post-transplant lymphoproliferative disorder in a transplanted colon
Post-transplant lymphoproliferative disorders
Post-transplant lymphoproliferative disease
Case-report: EBV driven lymphoproliferative disorder associated with Ruxolitinib
Adoptive Cell Transfer of Allogeneic Epstein-Barr Virus-Specific T Lymphocytes for Treatment of Refractory EBV-Associated Posttransplant Smooth Muscle Tumors : A Case Report
Characterization of Epstein-Barr virus (EBV)-infected cells in EBV-associated hemophagocytic lymphohistiocytosis in two patients with X-linked lymphoproliferative syndrome type 1 and type 2
Post-transplant Epstein–Barr Virus-Related Lymphoproliferative Disorder: A Case Report and Review of Literature
Automated quantification of Epstein-Barr virus in whole blood for post-transplant lymphoproliferative disorders monitoring
Expert Consensus on the Characteristics of Patients with Epstein–Barr Virus-Positive Post-Transplant Lymphoproliferative Disease (EBV+ PTLD) for Whom Standard-Dose Chemotherapy May be Inappropriate: A Modified Delphi Study
CAR-T cells targeting Epstein-Barr virus gp350 validated in a humanized mouse model of EBV infection and lymphoproliferative disease
Frequenz und Phänotyp Epstein-Barr Virus (EBV)-spezifischer T-Lymphozyten im Verlauf asymptomatischer EBV-Reaktivierungen gesunder Virusträger
Epstein–Barr virus (EBV) and polyomaviruses are detectable in oropharyngeal cancer and EBV may have prognostic impact
Endoscopic detection of an early manifestation of EBV-related post-transplant lymphoproliferative disorder in a transplanted colon
Post-transplant lymphoproliferative disorders
Post-transplant lymphoproliferative disease
Case-report: EBV driven lymphoproliferative disorder associated with Ruxolitinib
Adoptive Cell Transfer of Allogeneic Epstein-Barr Virus-Specific T Lymphocytes for Treatment of Refractory EBV-Associated Posttransplant Smooth Muscle Tumors : A Case Report
Characterization of Epstein-Barr virus (EBV)-infected cells in EBV-associated hemophagocytic lymphohistiocytosis in two patients with X-linked lymphoproliferative syndrome type 1 and type 2
Post-transplant Epstein–Barr Virus-Related Lymphoproliferative Disorder: A Case Report and Review of Literature
Automated quantification of Epstein-Barr virus in whole blood for post-transplant lymphoproliferative disorders monitoring
Expert Consensus on the Characteristics of Patients with Epstein–Barr Virus-Positive Post-Transplant Lymphoproliferative Disease (EBV+ PTLD) for Whom Standard-Dose Chemotherapy May be Inappropriate: A Modified Delphi Study
CAR-T cells targeting Epstein-Barr virus gp350 validated in a humanized mouse model of EBV infection and lymphoproliferative disease
Frequenz und Phänotyp Epstein-Barr Virus (EBV)-spezifischer T-Lymphozyten im Verlauf asymptomatischer EBV-Reaktivierungen gesunder Virusträger